Side Effects

What Is Ozempic Butt? The Science Behind GLP-1 Body Composition Changes

GLP-1 Companion · 6 min read

As GLP-1 medications like Ozempic and Wegovy have produced dramatic weight loss results, a wave of colloquial terms has emerged to describe the associated body changes. "Ozempic butt" (alongside "Ozempic face" and "Ozempic neck") refers to the flattened, deflated, or sagging appearance of the buttocks that some patients notice after losing significant weight. This article explains what is actually happening physiologically and what you can do about it.

What Is "Ozempic Butt"?

"Ozempic butt" is a colloquial term — not a medical diagnosis — describing the visual changes to the gluteal region that can occur after significant, rapid weight loss. These changes typically include one or more of the following:

• Loss of gluteal fat, resulting in a flatter or less rounded appearance
• Skin laxity (loose or sagging skin) in the buttocks and upper thigh area
• Reduction in the separation between the buttocks and thigh (the "banana fold")
• Loss of gluteal muscle (if resistance training is not maintained)

These changes are not unique to Ozempic or GLP-1 medications. They occur with any form of significant, rapid weight loss — including bariatric surgery, very low-calorie diets, or intensive exercise programs. Ozempic has become the cultural shorthand because of the widespread use of these medications and the pace at which weight can be lost.

Why Does It Happen?

Fat Loss Throughout the Body

GLP-1 medications cause fat loss throughout the body — there is no mechanism by which the medications can selectively reduce fat in one area while preserving it in another. The buttocks contain both subcutaneous fat (which provides the rounded aesthetic shape) and gluteal muscles. When overall caloric intake drops significantly, the body draws on fat stores from multiple regions, including the gluteal area.

Muscle Loss from Inadequate Protein and Exercise

In clinical trials, approximately 25–40% of weight lost on GLP-1 medications comes from lean mass (primarily muscle), with the remainder from fat. The gluteus maximus is the largest muscle in the body, and without deliberate resistance training and adequate protein intake, it is vulnerable to atrophy during aggressive caloric restriction.

Skin Laxity

Skin that has been stretched by excess fat for months or years may not retract fully when the fat is lost. The rate of weight loss matters: more gradual weight loss gives the skin's collagen matrix more time to remodel. Rapid weight loss — which is common on high-dose GLP-1 therapy — is more likely to leave loose skin behind.

Who Is Most at Risk?

• Patients who lose more than 15–20% of body weight rapidly
• Adults over 40 (lower baseline skin elasticity and collagen production)
• Those who start with a high BMI, particularly if they have carried excess weight for many years
• Patients who do not maintain resistance exercise during weight loss
• Those who do not meet protein intake targets

Evidence-Based Strategies to Prevent or Minimize Ozempic Butt

1. Prioritize Resistance Training

This is the single most effective intervention. Resistance training — particularly compound glute exercises such as squats, hip thrusts, Romanian deadlifts, and lunges — stimulates muscle protein synthesis and helps preserve (or even build) gluteal muscle mass even during a caloric deficit. Aim for 3–4 sessions per week with progressive overload.

2. Hit Your Protein Target

Adequate protein intake is essential for muscle preservation. Clinical guidelines for weight loss in patients on GLP-1 medications typically recommend 1.2–1.6 g of protein per kilogram of body weight per day. Because GLP-1 medications significantly reduce appetite, this requires deliberate effort — high-protein foods and protein shakes are often necessary to hit the target.

3. Slow Down Weight Loss if Possible

Working with your healthcare provider to maintain the lowest effective GLP-1 dose — rather than always escalating to the maximum — can slow the pace of weight loss and give the skin more time to remodel. A weight loss pace of 0.5–1% of body weight per week is generally considered optimal for preserving lean mass and minimizing skin laxity.

4. Skin-Supporting Habits

Hydration, collagen peptide supplements (with some evidence for improved skin elasticity), topical retinoids, and avoiding smoking can all support skin quality during weight loss.

What If It Has Already Happened?

If you have already experienced significant gluteal fat and skin changes, options include:

• Progressive resistance training: Even after weight loss, rebuilding gluteal muscle volume through training can significantly improve the shape and appearance of the buttocks.
• Body contouring procedures: Radiofrequency skin tightening (such as Thermage or Morpheus8) can modestly improve skin laxity in the buttocks area.
• Surgical options: For severe cases of skin redundancy after very large weight loss, surgical body contouring (buttock lift) may be considered, though this is typically reserved for patients who have completed weight loss and maintained stability for at least 12–18 months.

Keeping Perspective

The metabolic and cardiovascular health benefits of meaningful weight loss — lower blood pressure, improved blood sugar, reduced cancer risk, better sleep, improved joint health — far outweigh the cosmetic concerns of body composition changes for most patients. Many people find that with appropriate exercise and nutrition, their body composition improves significantly even if some cosmetic changes persist. The goal should be overall health, not reverting to a pre-weight-loss body shape.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Cava E et al. (2017). Preserving healthy muscle during weight loss. Adv Nutr.
• Heymsfield SB et al. (2014). Mechanisms, pathophysiology, and management of obesity. N Engl J Med.